Astrazeneca PLC DRC OLD (AZN)
AstraZeneca PLC DRC OLD is a NASDAQ-listed depositary receipt representing common stock of AstraZeneca PLC, a biopharmaceutical company headquartered in Cambridge, United Kingdom. Through its operating business, AstraZeneca is involved in the discovery, development, manufacture, and commercialization of prescription medicines. Its portfolio spans treatments in oncology, cardiovascular, renal and metabolism, respiratory and immunology, vaccines and immune therapies, and rare diseases. The company markets products such as Tagrisso, Imfinzi, Lynparza, Calquence, Farxiga/Forxiga, Brilinta/Brilique, Symbicort, and Beyfortus, among others. AstraZeneca serves physicians and healthcare channels across the UK, the US, Europe, Asia, Africa, and Australasia, and has also entered collaboration agreements with several partners to support research and development initiatives.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Analyst Price Target | Analyst Target Upside/Downside | Overall Financial Health | Market Cap | Free Float / Shares Outstanding | Payout Ratio |
|---|---|---|---|---|---|---|---|
|
NASDAQ-AZN
|
Not available
|
Not available
|
Not available
|
Great
|
286.6 B
|
99.5%
|
52.6%
|